Published on LinkedIn via Spencer Knight AbbVie has announced a $2.1 billion acquisition of Capstan Therapeutics to deepen its investment...

Published on LinkedIn via Benjamin McLeod Recent research reviewed by Benjamin McLeod highlights significant progress in using immune...

Published on LinkedIn via Spencer Knight The FDA has updated CAR-T therapy regulations for BMS’ Abecma and Breyanzi, removing REMS...

Published on The Straits Times Singapore’s expanded newborn screening programme now includes severe combined immunodeficiency (SCID),...

Published on Independent UK / LinkedIn via Spencer Knight A three-year-old girl with a rare disorder called AADC deficiency has become...

Published on Sin Chew Daily The Sarawak Society for Cell & Gene Therapy Research (SSCTR) has launched its official website to promote...

Published on Goldwater Institute The Goldwater Institute has submitted a Supreme Court brief challenging the FDA’s authority to regulate...

Published on Cytotherapy A recent publication in Cytotherapy reviewed 88 European guidance documents related to advanced therapy...

Published on HHS (LinkedIn) At a recent roundtable on cell and gene therapies, Health Secretary Robert F. Kennedy Jr., FDA Commissioner...

Published on Ministry of Science, Technology and Innovation (MOSTI) Malaysia has launched the second edition of its National...

Published on Science Researchers have demonstrated a method for generating CAR T cells inside the body using CD8-targeted lipid...

Published on CAR T Vision (via CAR T Vision Coalition website) A new international coalition, CAR T Vision, has launched with a bold...

In recent years, public interest in stem cell therapy has surged, often fueled by promises of anti-aging, disease reversal, and...

Published on The Associated Press Sarepta has suspended shipments of Elevidys and paused a trial arm after a second non-ambulatory...

Published on Spencer Knight via LinkedIn Eli Lilly has announced plans to acquire Verve Therapeutics in a deal worth up to $1.3 billion....

Published on Spencer Knight via LinkedIn Supernus Pharmaceuticals is acquiring Sage Therapeutics in a $795 million all-cash deal....

Published on Spencer Knight via LinkedIn BioNTech has signed a definitive agreement to acquire CureVac in an all-stock transaction valued...

Published on Spencer Knight via LinkedIn SpliceBio has secured €119 million in Series B funding, the largest ever for a biotech in...

Published on Spencer Knight via LinkedIn Missy Christy had already beaten cancer once. Then, as a new mother, she faced it again—this...

Published on Spencer Knight via LinkedIn Glioblastoma remains one of the deadliest brain cancers with limited treatment options. Two new...